Carisma Therapeutics Inc. (CARM)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.00
- As of
Kresmion compiles this page from CARM's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Carisma Therapeutics Inc. (CARM): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2025-12-05.
See the full CARM dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CARM on one page. Preview it with sample data, then open it live with a free account.
Preview the CARM dossierActive events for CARM
- mediumEarnings below estimates
Q1-2025: Missed consensus by 79.7% - EPS $-0.22 vs $-0.1224 estimate
- mediumEarnings below estimates
Q4-2024: Missed consensus by 153.3% - EPS $-0.42 vs $-0.1658 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 79.7% - EPS $-0.22 vs $-0.1224 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 150.5% - EPS $-0.23 vs $-0.0918 estimate
- mediumEarnings above estimates
Q3-2025: Beat consensus by 974.2% - EPS $1.07 vs $-0.1224 estimate
FREE, NO ACCOUNT
Every event on CARM, as it fires
New filings, 13F moves and cross asset events on CARM land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, CARM
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
CARM's 10-Q filed Nov 12, 2025 states:
As a result of these conditions, substantial doubt exists about the Company's ability to continue as a going concern.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on CARM
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CARM on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CARM in the last 180 days.
Upstream: SEC EDGAR filings for CARM
Kresmion, "Carisma Therapeutics Inc. (CARM) institutional holdings and SEC filings", data as of 2026-06-22, https://kresmion.com/research/CARM. Upstream data: SEC EDGAR filings for CARM.
Link to this data (HTML):
<a href="https://kresmion.com/research/CARM">Carisma Therapeutics Inc. (CARM) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CARM on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CARM for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.